Long COVID is when an individual who has contracted COVID-19 continues to experience symptoms of the virus (e.g. tiredness, fever, sleep difficulty, neurological, cognitive symptoms and more…), which are often severe, several weeks/months after initial infection. Over 2 million people in the UK have been affected by Long COVID and an estimated 20 million in the USA.
At Attomarker, we believe we are approaching potential answers to pressing questions on Long COVID. Antibodies are a vital part of our immune systems. When analysing patient antibody responses across a range of COVID variants, it is evident that individual immunity and hence how vulnerable a person is, noticeably varies. We call these individual responses immunity endotypes.
Around 2 million people in the UK have been affected by Long COVID
Estimated 20 million in the USA have been affected by Long COVID
Long Covid has negatively impacted over 1 million individuals’ daily lives and routines in the UK
Feeling exhausted/fatigued is one of the symptoms most reported by individuals who have long COVID
Attomarker Multi-Variant Antibody Immunity Spectrum Test
Adding Insight into the Immunology
Behind the Science
We have developed a Multi-Variant Antibody Immunity Spectrum Test, only requiring a fingerprick of blood, that we believe could be used in targeting treatments for Long Covid patients. It is a research test that, unlike our CE marked test, is not yet licensed to be sold to the public and is not available on the NHS, but the good news is that this promising new test and any subsequent treatment can be arranged privately with an appropriate clinician on a named patient basis. The clinician would be interested in your antibody immunity spectrum and seek to identify your endotype. The immunity spectrum could then inform a possible treatment in discussion with your doctor (and keep in mind that some drugs may be expensive).
We have formed a partnership with a clinic specialising in Long COVID (note this is a private clinic).